Skip to main content

2016-2017 Events

Ramille Shah
Assistant Professor of Materials Science and Engineering, Northwestern University
New Biomaterial Platforms for 3D Printing and Their Promise in Medicine, 10/12/2016

Zach Serber
Founder, Chief Science Officer, VP of Development, Zymergen
Using data to unravel the dark matter of genomes and improve traits, 11/02/2016

Keith Turner
Computational Microbiologist, Monsanto
Computational biology and data science in the agricultural biotech industry, 12/07/2016

Fang Lai
Vice President of R&D, Ohmx Corporation
The Role of Ohmx Platform Technology in the Diagnostic World, 01/25/2017

Cato T. Laurencin
Professor of Chemical and Biomolecular Engineering, Materials Science and Engineering, The University of Connecticut
Regenerative Engineering: Convergence To Address Grand Challenges, 02/16/2017

Alison Mastrangelo
Associate Research Fellow, Pfizer
Globetrotting: How My Engineering Degree Took Me Around the World and How Biosimilars Lured Me Back to the US, 03/15/2017

Hal Alper
Associate Professor of Chemical Engineering, University of Texas
Applications of Synthetic Biology and Evolution for Industrial Strain Development, 03/29/2017

Latonia Harris
Scientific Director, The Janssen Pharmaceutical Companies of Johnson & Johnson
Accelerated Biopharmaceutical Process Development Case Study:  New Product In-License through Expedited FDA Approval, 04/05/2017

Johan Kers
Program Director, Ginkgo Bioworks, Inc.
Making biology easier to engineer:  strategies to design custom microbes for multiple markets using a foundry model, 04/12/2017

Jared C. Lewis
Assistant Professor of Chemistry, University of Chicago
Protein engineering, directed evolution, & artificial metalloenzymes, 04/19/2017

Heather Pinkett
Associate Professor of Molecular Biosciences, Northwestern University
ATP Binding Cassette (ABC) transporters and their roles in cystic fibrosis, multiple drug resistance and the evolution of superbugs, 04/26/2017

Anne Plant
Chief of the Biosystems and Biomaterials Division, National Institute of Standards and Technology
Advancing rigorous quantitation of biological systems for better understanding and prediction of cell-based and other complex therapies, 05/03/2017

David Giljohann
Chief Executive Officer, Exicure
Biotherapeutics development, including regulatory aspects, 05/10/2017

Steve Little
Professor & Chair - Chemical and Petroleum Engineering; Professor of Bioengineering, Immunology, and Ophthalmology, University of Pittsburgh
Controlling Controlled Release, 05/17/2017

Tom Brieva
Director, New Product Platforms, Celgene Cellular Therapeutics
Cell-based pharmaceutical technology: Accomplishments, promise, and challenges, 05/24/2017

Stacey Finley
University of Southern California, Gabilan Assistant Professor of Biomedical Engineering
Systems biology approach to developing molecular-detailed computational models of biological processes related to human disease, 05/31/2017

Mikkel Algire
Abbvie, Senior Scientist II
My journey to understanding and impacting complex biological systems, 07/19/2017

Back to top
[system-view:external] [/system-view:external]